Kerala cuts out middlemen to reduce medicine costs, saves ₹18.5 crore on insulin purchases
Kerala’s medical corporation slashed procurement costs for essential drugs like insulin and Risdiplam by bypassing intermediaries and negotiating directly with manufacturers, successfully securing massive public savings and ensuring uninterrupted hospital supplies.
Read the full report on Onmanorama
Story file
- Section
- Health
- Places
- Kerala
- First reported by
- Onmanorama
- Reporter
- manoj kadambad
- Published
- Saturday, 10 October 2026, 6:29 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Onmanorama with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
